Anikha Bellad1,2, Satish Chandra Girimaji3, Babylakshmi Muthusamy4,5. 1. Institute of Bioinformatics, International Technology Park, Bangalore, 560066, India. 2. Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India. 3. Department of Child and Adolescent Psychiatry, NIMHANS, Hosur Road, Bangalore, 560029, India. girimaji@nimhans.ac.in. 4. Institute of Bioinformatics, International Technology Park, Bangalore, 560066, India. babylakshmi@ibioinformatics.org. 5. Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India. babylakshmi@ibioinformatics.org.
Abstract
BACKGROUND: Spastic paraplegia 50 (SPG50) is a rare autosomal recessive inherited disorder characterized by spasticity, severe intellectual disability and delayed or absent speech. Loss-of-function pathogenic mutations in the AP4M1 gene cause SPG50. METHODS: In this study, we investigated the clinical and genetic characteristics of a consanguineous family with two male siblings who had infantile hypotonia that progressed to spasticity, paraplegia in one and quadriplegia in the other patient. In addition, the patients also exhibited neurodevelopmental phenotypes including severe intellectual disability, developmental delay, microcephaly and dysmorphism. RESULTS: In order to identify the genetic cause, we performed cytogenetics, whole-exome sequencing and Sanger sequencing. Whole-exome sequencing of the affected siblings and unaffected parents revealed a novel exonic frameshift insertion of eight nucleotides (c.341_342insTGAAGTGC) on exon 4 of the AP4M1 gene. CONCLUSION: Insertion of these eight nucleotides in the AP4M1 gene is predicted to result in a premature protein product of 132 amino acids. The truncated protein product lacks a signal binding domain which is essential for protein-protein interactions and the transport of cargo proteins to the membrane. Thus, the identified variant is pathogenic and our study expands the knowledge of clinical and genetic features of SPG50.
BACKGROUND: Spastic paraplegia 50 (SPG50) is a rare autosomal recessive inherited disorder characterized by spasticity, severe intellectual disability and delayed or absent speech. Loss-of-function pathogenic mutations in the AP4M1 gene cause SPG50. METHODS: In this study, we investigated the clinical and genetic characteristics of a consanguineous family with two male siblings who had infantile hypotonia that progressed to spasticity, paraplegia in one and quadriplegia in the other patient. In addition, the patients also exhibited neurodevelopmental phenotypes including severe intellectual disability, developmental delay, microcephaly and dysmorphism. RESULTS: In order to identify the genetic cause, we performed cytogenetics, whole-exome sequencing and Sanger sequencing. Whole-exome sequencing of the affected siblings and unaffected parents revealed a novel exonic frameshift insertion of eight nucleotides (c.341_342insTGAAGTGC) on exon 4 of the AP4M1 gene. CONCLUSION: Insertion of these eight nucleotides in the AP4M1 gene is predicted to result in a premature protein product of 132 amino acids. The truncated protein product lacks a signal binding domain which is essential for protein-protein interactions and the transport of cargo proteins to the membrane. Thus, the identified variant is pathogenic and our study expands the knowledge of clinical and genetic features of SPG50.
Authors: Annemieke J M H Verkerk; Rachel Schot; Belinda Dumee; Karlijn Schellekens; Sigrid Swagemakers; Aida M Bertoli-Avella; Maarten H Lequin; Jeroen Dudink; Paul Govaert; A L van Zwol; Jennifer Hirst; Marja W Wessels; Coriene Catsman-Berrevoets; Frans W Verheijen; Esther de Graaff; Irenaeus F M de Coo; Johan M Kros; Rob Willemsen; Patrick J Willems; Peter J van der Spek; Grazia M S Mancini Journal: Am J Hum Genet Date: 2009-06-25 Impact factor: 11.025
Authors: Darius Ebrahimi-Fakhari; Julian Teinert; Robert Behne; Miriam Wimmer; Angelica D'Amore; Kathrin Eberhardt; Barbara Brechmann; Marvin Ziegler; Dana M Jensen; Premsai Nagabhyrava; Gregory Geisel; Erin Carmody; Uzma Shamshad; Kira A Dies; Christopher J Yuskaitis; Catherine L Salussolia; Daniel Ebrahimi-Fakhari; Toni S Pearson; Afshin Saffari; Andreas Ziegler; Stefan Kölker; Jens Volkmann; Antje Wiesener; David R Bearden; Shenela Lakhani; Devorah Segal; Anaita Udwadia-Hegde; Andrea Martinuzzi; Jennifer Hirst; Seth Perlman; Yoshihisa Takiyama; Georgia Xiromerisiou; Katharina Vill; William O Walker; Anju Shukla; Rachana Dubey Gupta; Niklas Dahl; Ayse Aksoy; Helene Verhelst; Mauricio R Delgado; Radka Kremlikova Pourova; Abdelrahim A Sadek; Nour M Elkhateeb; Lubov Blumkin; Alejandro J Brea-Fernández; David Dacruz-Álvarez; Thomas Smol; Jamal Ghoumid; Diego Miguel; Constanze Heine; Jan-Ulrich Schlump; Hendrik Langen; Jonathan Baets; Saskia Bulk; Hossein Darvish; Somayeh Bakhtiari; Michael C Kruer; Elizabeth Lim-Melia; Nur Aydinli; Yasemin Alanay; Omnia El-Rashidy; Sheela Nampoothiri; Chirag Patel; Christian Beetz; Peter Bauer; Grace Yoon; Mireille Guillot; Steven P Miller; Thomas Bourinaris; Henry Houlden; Laura Robelin; Mathieu Anheim; Abdullah S Alamri; Adel A H Mahmoud; Soroor Inaloo; Parham Habibzadeh; Mohammad Ali Faghihi; Anna C Jansen; Stefanie Brock; Agathe Roubertie; Basil T Darras; Pankaj B Agrawal; Filippo M Santorelli; Joseph Gleeson; Maha S Zaki; Sarah I Sheikh; James T Bennett; Mustafa Sahin Journal: Brain Date: 2020-10-01 Impact factor: 15.255